newsfilter
← Latest News
GlobeNewswire·

Matinas BioPharma Reports 2022 Financial Results and Provides a Business Update

Near-term data readouts from internal and collaborative programs expected to support advancement of the LNC platform for delivery of nucleic acids FDA feedback from MAT2203 Type B meeting expected to impact